Kalvista Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$11.48(as of Oct 8, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Kalvista Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$11.48
Ticker SymbolKALV
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees270
CountyUSA
Market Cap$551.7M

KalVista Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is EKTERLY, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. KalVista Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

Kalvista Pharmaceuticals Inc In Our Stock Scanner

As of Oct 09, 2025
As of ---
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.